Stem cells have an innate property that attracts them to inflammation in the body. Studies have shown that stem cells can regenerate damaged or diseased tissues, reduce inflammation and modulate the immune system promoting better health and quality of life.
A 2019 study conducted by Huang et al., involving 64 Rheumatoid Arthritis (RA) patients, found that Mesenchymal Stem cell therapy is a safe treatment option. (3). All of the patients in the study showed no long term abnormalities in their routine blood examinations.
The study also found that Mesenchymal Stem Cell Therapy was an effective treatment option for Rheumatoid Arthritis
“There were significant decreases for the Inflammatory and/or RA Serological Makers, including ESR, CRP, RF, and anti-CCP at one year and three years after treatment. Compared with the pretreatment level from patients with RA, they showed decreased levels of ESR, CRP, RF, and anti-CCP after one year and three-year post-treatment.” (3)
The research concluded that long-term efficacy was achieved with umbilical cord tissue-derived mesenchymal stem cell treatment. (3)